Global GMP Grade Fetal Bovine Serum Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global GMP Grade Fetal Bovine Serum Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Fetal bovine serum (FBS) is the liquid fraction of clotted blood from fetal calves, depleted of cells, fibrin and clotting factors, but containing a large number of nutritional and macromolecular factors essential for cell growth. Bovine serum albumin is the major component of FBS
GMP Grade Fetal Bovine Serum report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global GMP Grade Fetal Bovine Serum market is projected to reach US$ 868 million in 2029, increasing from US$ 675 million in 2022, with the CAGR of 3.6% during the period of 2024 to 2029. Demand from Vaccine Production and Biopharma Production are the major drivers for the industry.
The animal serum product market is primarily driven by its extensive use in various applications, including cell culture, biopharmaceutical production, and diagnostics. Fetal bovine serum (FBS) and other animal-derived sera contain essential nutrients and growth factors necessary for cell growth and viability, making them indispensable in research and industrial processes. Moreover, the increasing demand for biologics and personalized medicine fuels the need for high-quality animal serum products to support cell-based therapies and recombinant protein production. However, the market also faces challenges, notably concerns about ethical considerations and the risk of contaminations associated with animal-derived products. There is a growing push towards animal-free and defined media alternatives to address these challenges. Additionally, the variability in serum composition from different sources and batches poses a challenge in ensuring consistent and reproducible results in cell-based research and biomanufacturing.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global GMP Grade Fetal Bovine Serum market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Thermo Fisher
Cytiva
Merck
Moregate BioTech
Gemini
R&D Systems
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
PAN-Biotech
Segment by Type
North America-sourced
South America-sourced
Australia-sourced
Others
Vaccine Production
Biopharma Production
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the GMP Grade Fetal Bovine Serum market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of GMP Grade Fetal Bovine Serum, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the GMP Grade Fetal Bovine Serum industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of GMP Grade Fetal Bovine Serum in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, GMP Grade Fetal Bovine Serum introduction, etc. GMP Grade Fetal Bovine Serum Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of GMP Grade Fetal Bovine Serum market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
GMP Grade Fetal Bovine Serum report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global GMP Grade Fetal Bovine Serum market is projected to reach US$ 868 million in 2029, increasing from US$ 675 million in 2022, with the CAGR of 3.6% during the period of 2024 to 2029. Demand from Vaccine Production and Biopharma Production are the major drivers for the industry.
The animal serum product market is primarily driven by its extensive use in various applications, including cell culture, biopharmaceutical production, and diagnostics. Fetal bovine serum (FBS) and other animal-derived sera contain essential nutrients and growth factors necessary for cell growth and viability, making them indispensable in research and industrial processes. Moreover, the increasing demand for biologics and personalized medicine fuels the need for high-quality animal serum products to support cell-based therapies and recombinant protein production. However, the market also faces challenges, notably concerns about ethical considerations and the risk of contaminations associated with animal-derived products. There is a growing push towards animal-free and defined media alternatives to address these challenges. Additionally, the variability in serum composition from different sources and batches poses a challenge in ensuring consistent and reproducible results in cell-based research and biomanufacturing.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global GMP Grade Fetal Bovine Serum market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Thermo Fisher
Cytiva
Merck
Moregate BioTech
Gemini
R&D Systems
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
PAN-Biotech
Segment by Type
North America-sourced
South America-sourced
Australia-sourced
Others
Segment by Application
Vaccine Production
Biopharma Production
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the GMP Grade Fetal Bovine Serum market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of GMP Grade Fetal Bovine Serum, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the GMP Grade Fetal Bovine Serum industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of GMP Grade Fetal Bovine Serum in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, GMP Grade Fetal Bovine Serum introduction, etc. GMP Grade Fetal Bovine Serum Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of GMP Grade Fetal Bovine Serum market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices